Profile and investment
| Fund type | Open Ended Investment Company |
|---|---|
| Investment style (stocks) | Market Cap: Mid Investment Style: Growth |
| Morningstar category | Health |
| Launch date | 22 Mar 2022 |
| Price currency | USD |
| Domicile | United States |
| Symbol | EKG |
| Manager & start date | Roger Testin 22 Mar 2022 Daniel Lindquist 22 Mar 2022 Jon Erickson 22 Mar 2022 David McGarel 22 Mar 2022 Stan Ueland 22 Mar 2022 Chris Peterson 22 Mar 2022 Erik Russo 22 Mar 2022 |
| Pricing frequency | Daily |
|---|---|
| Total net assets | 2.70m USD As of Feb 28 2026 |
| Share class size | 2.70m USD As of Feb 28 2026 |
| Net expense ratio | 0.65% |
| Front end load | -- |
| Deferred load | -- |
| Maximum Redemption Fee | -- |
| Min. initial investment | -- |
| Min. additional investment | -- |
| Initial IRA | -- |
| Additional IRA | -- |
| Available for sale | United States |
More ▼
Top 5 holdings
| Top 5 holdings as a per cent of portfolio | |||
|---|---|---|---|
| 44.62% | 39.63% | 0.00% | 39.63% |
| Category average | % Net assets | % Short | % Long |
| Company | 1 year change | Portfolio weight | Long allocation |
|---|---|---|---|
| Intuitive Surgical Inc ISRG:NSQ | -12.56% | 9.29% | |
| Dexcom Inc DXCM:NSQ | -13.75% | 8.57% | |
| Resmed Inc RMD:NYQ | +14.07% | 8.12% | |
| IQVIA Holdings Inc IQV:NYQ | -3.95% | 7.76% | |
| Guardant Health Inc GH:NSQ | +117.02% | 5.89% | |
| Per cent of portfolio in top 5 holdings: 39.63% |
Asset type
| US stock | 98.69% |
| Non-US stock | 1.16% |
| Cash | 0.15% |
| US bond | 0.00% |
| Non-US bond | 0.00% |
| Other | 0.00% |
Top 5 sectors
| Healthcare | 99.85% |
Top 5 regions
| United States | 98.69% |
| Latin America | 1.16% |
Sector and region weightings are calculated using only long position holdings of the portfolio.
